 Basic studies new material antitumor immune cells adoptive immunotherapy cancer lymphokine killer LAK cells therapy several problems difficulty sterilization time consumption problems new materials able antitumor immune cells mitogen PWM PWM-conjugated materials strong killer cells short-term stimulation human peripheral blood lymphocytes PBL induced killer cells wide spectrum vitro human tumor cell lines Hela KB Human PBL short time tumoricidal effect tumor bearing nude mice results problems LAK therapy applicable extracorporeal immunotherapy cancer